Skip to content

COLLEGIUM PHARMACEUTICAL, INC

COLL · XNAS

CIK 1267565fmd_10WRDHDSWWFQVWCJ6PE31B1H9NManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods

Latest annual · FY2025

Millions
Total revenues
781
Gross profit
463
Operating income
180
Net income
63
Free cash flow
328

Latest quarter · Q3 FY2026

Millions
Total revenues
216
Gross profit
125
Operating income
29
Net income
22
Free cash flow
86

Daily close · COLLIEX trades only

Nov 13, 2025 to Nov 11, 2026 · 250 sessions

24.77 USD

20304050Nov 13, 2025May 14, 2026Nov 11, 2026Vol

Built from trades executed at IEX only, one exchange with a small share of US volume. This is not the consolidated tape. The close is the last IEX trade of the session, not the official closing price. Earlier sessions are divided by the later split ratios the API confirmed against IEX prices; dividends are not adjusted. Switch to As traded for the prices as they printed. End of day, not real time: a session is published the day after it trades.

Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. iex.io/legal/hist-data-terms

Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2022 to FY2025
+18.9%
Revenue, 5 yearsFY2020 to FY2025
+20.3%
Net income, 5 yearsFY2020 to FY2025
+18.6%

COLLEGIUM PHARMACEUTICAL, INC (COLL) financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2025FY2024ChangeSource
Revenue$780.6 million$631.4 million+23.6%10-K 2026-02-26 · proof
Gross profit$463.3 million$377.3 million+22.8%10-K 2026-02-26 · proof
Operating income$179.6 million$169.9 million+5.7%10-K 2026-02-26 · proof
Net income$62.9 million$69.2 million-9.1%10-K 2026-02-26 · proof
Cash from operating activities$329.3 million$205 million+60.7%10-K 2026-02-26 · proof
Free cash flow$327.6 million$203.3 million+61.1%10-K 2026-02-26 · proof
Total assets$1.7 billion$1.7 billion-0.4%10-K 2026-02-26 · proof
Total liabilities$1.4 billion$1.4 billion-5.5%10-K 2026-02-26 · proof
Cash and cash equivalents$231.3 million$70.6 million+227.7%10-K 2026-02-26 · proof
What was COLLEGIUM PHARMACEUTICAL, INC (COLL)'s revenue in fiscal 2025?
COLLEGIUM PHARMACEUTICAL, INC (COLL) reported revenue of $780.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $631.4 million the year before (+23.6%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What was COLLEGIUM PHARMACEUTICAL, INC (COLL)'s gross profit in fiscal 2025?
COLLEGIUM PHARMACEUTICAL, INC (COLL) reported gross profit of $463.3 million for fiscal 2025 (the year ended Dec 31, 2025), against $377.3 million the year before (+22.8%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What was COLLEGIUM PHARMACEUTICAL, INC (COLL)'s operating income in fiscal 2025?
COLLEGIUM PHARMACEUTICAL, INC (COLL) reported operating income of $179.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $169.9 million the year before (+5.7%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What was COLLEGIUM PHARMACEUTICAL, INC (COLL)'s net income in fiscal 2025?
COLLEGIUM PHARMACEUTICAL, INC (COLL) reported net income of $62.9 million for fiscal 2025 (the year ended Dec 31, 2025), against $69.2 million the year before (-9.1%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What was COLLEGIUM PHARMACEUTICAL, INC (COLL)'s cash from operating activities in fiscal 2025?
COLLEGIUM PHARMACEUTICAL, INC (COLL) reported cash from operating activities of $329.3 million for fiscal 2025 (the year ended Dec 31, 2025), against $205 million the year before (+60.7%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What was COLLEGIUM PHARMACEUTICAL, INC (COLL)'s free cash flow in fiscal 2025?
COLLEGIUM PHARMACEUTICAL, INC (COLL) reported free cash flow of $327.6 million for fiscal 2025 (the year ended Dec 31, 2025), against $203.3 million the year before (+61.1%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What are COLLEGIUM PHARMACEUTICAL, INC (COLL)'s total assets?
As of Dec 31, 2025, COLLEGIUM PHARMACEUTICAL, INC (COLL) reported total assets of $1.7 billion, against $1.7 billion a year earlier (-0.4%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What are COLLEGIUM PHARMACEUTICAL, INC (COLL)'s total liabilities?
As of Dec 31, 2025, COLLEGIUM PHARMACEUTICAL, INC (COLL) reported total liabilities of $1.4 billion, against $1.4 billion a year earlier (-5.5%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC
What are COLLEGIUM PHARMACEUTICAL, INC (COLL)'s cash and cash equivalents?
As of Dec 31, 2025, COLLEGIUM PHARMACEUTICAL, INC (COLL) reported cash and cash equivalents of $231.3 million, against $70.6 million a year earlier (+227.7%). Source: the 10-K filed with the SEC on Feb 26, 2026. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:COLL&period_type=annual&limit=5"

Information only, not investment advice.